Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma.
暂无分享,去创建一个
Joe Y. Chang | T. Guerrero | K. Forster | C. Stevens | M. McAleer | R. Komaki | Z. Liao | W. Smythe | A. Vaporciyan | H. Liu | A. Correa | D. Rice | M. Jeter | C. Stevens | D. Rice | H. Liu
[1] Randall K Ten Haken,et al. Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis. , 2006, International journal of radiation oncology, biology, physics.
[2] Laurence Court,et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. , 2006, International journal of radiation oncology, biology, physics.
[3] P. van Luijk,et al. Influence of adjacent low-dose fields on tolerance to high doses of protons in rat cervical spinal cord. , 2006, International journal of radiation oncology, biology, physics.
[4] Helen H Liu,et al. Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. , 2006, International journal of radiation oncology, biology, physics.
[5] S. Swisher,et al. Extended surgical staging for potentially resectable malignant pleural mesothelioma. , 2005, The Annals of thoracic surgery.
[6] L. Marks,et al. Challenges in defining radiation pneumonitis in patients with lung cancer. , 2005, International journal of radiation oncology, biology, physics.
[7] C. Thieke,et al. Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the palliative treatment of malignant mesothelioma of the pleura: the Heidelberg experience. , 2005, Lung cancer.
[8] T. Guerrero,et al. Extrapleural pneumonectomy followed by IMRT: Results of a phase I/II study , 2005 .
[9] R. Fisher,et al. Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy. , 2005, International Journal of Radiation Oncology, Biology, Physics.
[10] Andrew Jackson,et al. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. , 2004, International journal of radiation oncology, biology, physics.
[11] Joe Y. Chang,et al. Promising Early Local Control of Malignant Pleural Mesothelioma Following Postoperative Intensity Modulated Radiotherapy (IMRT) to the Chest , 2003, Cancer journal.
[12] K. Rosenzweig,et al. Hemithoracic radiation after extrapleural pneumonectomy for malignant pleural mesothelioma. , 2003, International journal of radiation oncology, biology, physics.
[13] Claude Denham,et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] K. Forster,et al. Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: clinical implementation. , 2003, International journal of radiation oncology, biology, physics.
[15] K. Forster,et al. Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma. , 2003, International journal of radiation oncology, biology, physics.
[16] C. Fiorino,et al. Lethal pulmonary complications significantly correlate with individually assessed mean lung dose in patients with hematologic malignancies treated with total body irradiation. , 2002, International journal of radiation oncology, biology, physics.
[17] R. Cameron,et al. Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma. , 2001, The Journal of thoracic and cardiovascular surgery.
[18] M T Munley,et al. Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer. , 2001, International journal of radiation oncology, biology, physics.
[19] K. Rosenzweig,et al. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. , 2001, The Journal of thoracic and cardiovascular surgery.
[20] C C Ling,et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[21] V. Rusch,et al. Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. , 1999, The Annals of thoracic surgery.
[22] R K Ten Haken,et al. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. , 1999, International journal of radiation oncology, biology, physics.
[23] J A Purdy,et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) , 1999, International journal of radiation oncology, biology, physics.
[24] R K Ten Haken,et al. Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. , 1998, International journal of radiation oncology, biology, physics.
[25] D. Sugarbaker,et al. Patterns of failure after trimodality therapy for malignant pleural mesothelioma. , 1997, The Annals of thoracic surgery.
[26] S. Steinberg,et al. Surgically debulked malignant pleural mesothelioma: Results and prognostic factors , 1996, Annals of Surgical Oncology.
[27] G. Kutcher,et al. Technique for external beam treatment for mesothelioma. , 1987, International journal of radiation oncology, biology, physics.
[28] W. Richards,et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. , 1999, The Journal of thoracic and cardiovascular surgery.